Please assess the completion status of the following clinical trial:

Trial Title: A Psychosocial Intervention Plus Early Palliative Care in the Reduction of Depression of Advanced Cancer Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 years and \<75 years;~* Adequate knowledge about the cancer diagnosis;~* Starting first line palliative antineoplastic treatment;~* Eastern Cooperative Oncology Group Performance Status (ECOG-PS) ≤ 2;~* Life expectancy\> 6 months and \<24 months (as per the medical oncologist);~* Must have on the following diagnoses:~Metastatic or unresectable recurrent breast cancer; Stage IIIC or IV recurrent platinum-resistant ovarian cancer; Metastatic or unresectable recurrent cervix cancer; Metastatic or unresectable recurrent endometrial cancer; Metastatic or unresectable recurrent head and neck cancer (after previous radiotherapy); Hormone-refractory metastatic or unresectable recurrent prostate cancer; Metastatic or unresectable recurrent genitourinary cancer; Metastatic or unresectable recurrent non-small cell lung cancer; Extensive-stage or recurrent small cell lung cancer; Metastatic or unresectable recurrent gastrointestinal cancer;~Exclusion Criteria:~* Currently undergoing any psychological treatment due to a psychological disorder;~* Currently using antidepressants to treat depressive disorders and / or anxiety;~* Any cognitive deficit or attention problem that could interfere in the ability to answer questionnaires or understand the study aims (as per investigator);~* Current or previous established diagnosis of any of the following psychological conditions: Substance-Related Disorders; Schizophrenia and Other Psychotic Disorders; Mood Disorders (Depressive Disorders, Bipolar Disorders); Anxiety Disorders; Dissociative Disorders; Personality Disorders; and / or a history of suicide attempt;~* Patients with single resected metastasis;~* Any co-morbid condition, which, in the opinion of the investigator, could interfere with the safety, the compliance with the study or with the interpretation of the results.~* Patients unable to go to the hospital for the study visits, regardless of the reason.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Standard oncologic care (Type: NO_INTERVENTION): Standard oncologic care
- Early Palliative Care (Type: EXPERIMENTAL): A first medical consult at the Palliative Care Service will be scheduled after 2 to 3 weeks from the study inclusion and every 3 to 4 weeks thereafter.
- Psychosocial plus early Palliative Care (Type: EXPERIMENTAL): Five weekly sessions of a Brief Psychosocial Intervention based of Behavioral Cognitive Therapy plus early palliative care. Regarding the early Palliative Care, a first medical consult at the Palliative Care Service will be scheduled after 2 to 3 weeks from the study inclusion and every 3 to 4 weeks thereafter.

Based on this trial design, predict the completion outcome and termination type (if applicable).